Cancer clinical trials are an important part of cancer research and treatment. These studies aim to find new and better ways to prevent, diagnose, and treat cancer.

The Cancer Partners of Nebraska pharmacy recently received accreditation from ACHC to help provide pharmacy care for those suffering from cancer. This new accreditation allows for a higher standard of care for patients in the area.

When you or a loved one is affected by cancer, you begin to consider your options of where you should receive care. Being close to home is essential for most and is usually where you want to be for several reasons. Our mission is to ensure we give patients access to state-of-the-art, high-quality, affordable cancer care in a community-based setting.

When it comes to fighting cancer, we have the most advanced radiation technology available today, here in Lincoln. The Edge is an advanced linear accelerator used to treat a wide range of cancers.

Two local cancer patients are the first in the area to receive a new treatment for prostate cancer. Cancer Partners is the first in Lincoln to offer PLUVICTO(TM) (lutetium Lu 177 vipivotide tetraxetan) which is a drug that targets PSMA – a protein found on the surface of most prostate cancer cells.

Cancer Partners of Nebraska is excited to announce the addition of Dr. Jacqueline Kelly to our team. She brings a vast depth of knowledge to our cutting-edge Radiation Oncology team.